| Antidiabetic phytoconstituents and their mode of action on metabolic pathways SK Bharti, S Krishnan, A Kumar, A Kumar Therapeutic Advances in Endocrinology and metabolism 9 (3), 81-100, 2018 | 205 | 2018 |
| Why Chitosan? From properties to perspective of mucosal drug delivery A Kumar, A Vimal, A Kumar International journal of biological macromolecules 91, 615-622, 2016 | 196 | 2016 |
| Current and novel therapeutic molecules and targets in Alzheimer's disease A Kumar, CM Nisha, C Silakari, I Sharma, K Anusha, N Gupta, P Nair, ... Journal of the Formosan Medical Association 115 (1), 3-10, 2016 | 172 | 2016 |
| Molecular Docking and In Silico ADMET Study Reveals Acylguanidine 7a as a Potential Inhibitor of β‐Secretase CM Nisha, A Kumar, P Nair, N Gupta, C Silakari, T Tripathi, A Kumar Advances in bioinformatics 2016 (1), 9258578, 2016 | 147 | 2016 |
| Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy S Verma, A Kumar, T Tripathi, A Kumar Journal of Pharmacy and Pharmacology 70 (8), 985-993, 2018 | 116 | 2018 |
| Docking and ADMET prediction of few GSK-3 inhibitors divulges 6-bromoindirubin-3-oxime as a potential inhibitor CM Nisha, A Kumar, A Vimal, BM Bai, D Pal, A Kumar Journal of Molecular Graphics and modelling 65, 100-107, 2016 | 107 | 2016 |
| Targeting oxidative stress through antioxidants in diabetes mellitus P Thakur, A Kumar, A Kumar Journal of drug targeting 26 (9), 766-776, 2018 | 87 | 2018 |
| Therapeutic molecules against type 2 diabetes: What we have and what are we expecting? A Kumar, SK Bharti, A Kumar Pharmacological Reports 69 (5), 959-970, 2017 | 59 | 2017 |
| Type 2 Diabetes Mellitus: The Concerned Complications and Target Organs A Kumar, SK Bharti, A Kumar Apollo Medicine 11 (3), 161-166, 2014 | 39 | 2014 |
| The virtuous potential of chitosan oligosaccharide for promising biomedical applications A Kumar, A Kumar Journal of Materials Research 35 (9), 1123-1134, 2020 | 32 | 2020 |
| Mucosal and transdermal vaccine delivery strategies against COVID-19 A Kumar, A Kumar Drug Delivery and Translational Research 12 (5), 968-972, 2022 | 22 | 2022 |
| Obesity: single house for many evils. A Kumar, BP Nayak Minerva endocrinologica, 2015 | 16 | 2015 |
| CHITOSAN AS A BIOMEDICAL MATERIAL: PROPERTIES AND APPLICATIONS A Kumar, A Kumar Biopolymers: Structure, Performance and Applications, 2017 | 12 | 2017 |
| Development and characterization of tripolymeric and bipolymeric composite films using glyoxal as a potent crosslinker for biomedical application A Kumar, A Kumar Materials Science and Engineering: C 73, 333-339, 2017 | 11 | 2017 |
| Non-small-cell lung cancer-associated gene mutations and inhibitors A Kumar, A Kumar Advances in Cancer Biology - Metastasis 6, 10076, 2022 | 8 | 2022 |
| Fabrication of eggshell membrane–based novel buccal mucosa–mimetic surface and mucoadhesion testing of chitosan oligosaccharide films A Kumar, A Kumar Journal of Materials Research 34 (22), 3777-3786, 2019 | 8 | 2019 |
| Poly (lactic acid) and poly (lactic-co-glycolic) acid nanoparticles: versatility in biomedical applications A Kumar, A Kumar Materials for Biomedical Engineering: Absorbable Polymers, 2019 | 6 | 2019 |
| Alzheimer’s disease therapy: present and future molecules A Kumar, A Kumar Computational modeling of drugs against Alzheimer’s disease, 3-22, 2018 | 6 | 2018 |
| Chitosan-Based Drug Conjugated Nanocomposites: Advances and Innovation in Cancer Therapy A Kumar, A Kumar Regenerative Engineering and Translational Medicine, 2023 | 5 | 2023 |
| In Vitro Evaluation of Insulin Release from Chitosan-Alginate Macrobeads A Kumar, P Thakur, A Kumar Journal of Pharmaceutical Investigation 17, 546-554, 2022 | 4 | 2022 |
Awanish KumarAssociate Professor, National Institute of Technology, Raipur, India在 nitrr.ac.in 的电子邮件经过验证
